FY2024 Earnings Estimate for SIGA Issued By Edison Inv. Res

SIGA Technologies, Inc. (NASDAQ:SIGA) – Edison Inv. Res issued their FY2024 earnings per share estimates for shares of SIGA Technologies in a report released on Monday, November 18th. Edison Inv. Res analyst J. Prakash expects that the company will post earnings per share of $1.04 for the year. Edison Inv. Res also issued estimates for SIGA Technologies’ FY2025 earnings at $1.25 EPS.

SIGA Technologies Trading Up 3.3 %

Shares of SIGA opened at $6.48 on Thursday. The company has a market capitalization of $462.67 million, a PE ratio of 5.40 and a beta of 0.89. SIGA Technologies has a 12-month low of $4.26 and a 12-month high of $12.83. The business’s 50 day moving average is $7.03 and its 200 day moving average is $7.88.

SIGA Technologies (NASDAQ:SIGA) last issued its quarterly earnings results on Thursday, November 7th. The company reported $0.02 earnings per share for the quarter. The business had revenue of $10.01 million for the quarter. SIGA Technologies had a net margin of 49.33% and a return on equity of 49.06%.

Institutional Investors Weigh In On SIGA Technologies

Institutional investors have recently made changes to their positions in the company. Hotchkis & Wiley Capital Management LLC lifted its holdings in shares of SIGA Technologies by 152.6% in the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 2,048,440 shares of the company’s stock worth $13,827,000 after buying an additional 1,237,620 shares during the period. American Century Companies Inc. lifted its stake in SIGA Technologies by 251.2% in the second quarter. American Century Companies Inc. now owns 841,759 shares of the company’s stock worth $6,389,000 after acquiring an additional 602,091 shares during the period. Foundry Partners LLC bought a new position in SIGA Technologies during the 3rd quarter worth about $2,801,000. Denali Advisors LLC purchased a new position in SIGA Technologies during the 2nd quarter valued at about $1,815,000. Finally, Harbor Capital Advisors Inc. bought a new stake in shares of SIGA Technologies in the 3rd quarter valued at about $1,098,000. Institutional investors own 55.40% of the company’s stock.

About SIGA Technologies

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.